DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
Indian Express
0 shares
1 views
You might like
Related news coverage
COVID-19, Impacts And ASEAN Response: Pushing Back Vaccine Nationalism – Analysis
Eurasia Review
As ASEAN economic ministers meet virtually this week to deal with, among other things, the severe impacts of COVID-19, their..
-
Phase II trial of Oxford COVID-19 vaccine candidate to begin in PGI Chandigarh
Mid-Day
-
COVID-19 vaccine: Happy to be part of noble, global effort, says Pune trial volunteer
Mid-Day
-
Maharashtra records 14,888 new COVID-19 cases, 295 deaths; Human trial of Oxford vaccine begins in Pune
Zee News
-
Maharashtra records 14,888 new COVID-19 cases, 295 deaths; Human trial of Oxford vaccine begins in Pune
Zee News
Advertisement
More coverage
Russia in touch with India for collaboration to manufacture COVID-19 vaccine Sputnik V: Health Ministry
Mid-Day
In a significant development related to the *COVID-19 *vaccine, Russia has expressed its willingness to the Indian government for..
-
Oxford vaccine`s Phase 2 human trial may start at Pune hospital from August 26
Zee News
-
Oxford vaccine's Phase 2 human trial may start at Pune hospital from August 26
Zee News
-
Phase 2 trial of Oxford COVID-19 vaccine candidate to begin today
Mid-Day
-
Catholic Aussie archbishop calls for ethical coronavirus vaccine
CNA